Overview

Tolosa-Hunt syndrome (THS) is a rare condition that causes severe pain around the eyes, typically one eye, and can make it difficult to move the eye properly. THS cases occur in approximately 1-2 people per million.¹ Although the precise aetiology is unclear, THS is believed to be caused by the inflammation in the cavernous sinus (located beneath the brain and behind the eyes), which affects the nerves that control eye movement.² 

THS causes severe headaches around the eye and difficulty moving the eye can last from weeks to months, with attacks recurring in intervals of months or years. THS was first described in 1954 and doctors still experience difficulty diagnosing it.³ This article outlines the clinical presentation, diagnostic process, treatment options, and prognosis of THS.

Symptoms of Tolosa-Hunt syndrome

People with THS usually experience sudden, severe painful ophthalmoplegia (eye muscle paralysis or weakness) around one eye. This pain may fluctuate and persist for days to months. Other symptoms include:

• Eye movement difficulty: It could become hard to move the affected eye properly
• Drooping eyelid: The upper eyelid on the affected side could droop
• Double vision: People with THS could see double because the eye movements are affected
• Mild swelling or redness: Some people may notice slight swelling around the eye
• Eye bulge: The eye could abnormally protrude
• Dilated pupil: Dark center of the eye widens
• Numbness: Some people experience mild numbness around the forehead or cheek

These symptoms often lead people to seek medical help, however, they can be mistaken for other serious conditions, such as:

• Head trauma
• Recurrent painful ophthalmoplegic neuropathy
• Chronic migraine with ophthalmoplegia
• Tension headaches
• Diabetic ischemic oculomotor nerve palsy 
• Vascular lesions (e.g., cavernous carotid fistula or thrombosis)
• Brain tumours (e.g., meningioma, pituitary adenoma)
• Infections (e.g., sinusitis, tuberculosis)
• Inflammatory diseases (sarcoidosis, granulomatosis with polyangiitis)
• Giant cell arteritis

How is Tolosa-Hunt syndrome diagnosed?

Diagnosing THS can be challenging for healthcare professionals.⁴ There is no single test that confirms THS, therefore, doctors methodically rule out other possibilities. Diagnostic criteria for THS can be found in the 3rd edition of the International Classification of Headache Disorders (ICHD-3). The diagnostic criteria are summarised in Table 1. 

Table 1: Tolosa-Hunt diagnosis criteria according to the ICHD-3.

The following tests are conducted by healthcare professionals in order to diagnose THS:

Imaging tests

• Magnetic resonance imaging (MRI) scan: MRIs assists doctors in imaging inflammation in the cavernous sinus or areas near the eye
• Computed tomography (CT) scan: CT scans are sometimes used to rule out tumours or blood vessel problems
• Magnetic resonance angiography (MRA): Helps to identify issues with blood vessels near the eye⁵

Laboratory tests

• Blood tests: These are done to rule out infections or autoimmune diseases
• Lumbar puncture (spinal tap): In rare cases, fluid from around the brain may be tested to rule out infections⁶

Treatment of Tolosa-Hunt syndrome

The most common treatment for THS is corticosteroids, in oral and intravenous (IV) forms, which help reduce inflammation and ease symptoms rapidly (usually within a few days).¹ Debate still remains surrounding the optimal route of administration, dosage and length of treatment in special cases, such as children and pregnant women.¹

Corticosteroid therapy

• High-dose prednisone: A type of steroid tablet
• Intravenous (IV) steroids: If symptoms are very severe, doctors may give steroids through an IV. Steroids are tapered off over weeks to prevent symptoms from returning⁷

Other treatments

• Immunosuppressants: If steroids are ineffective, professionals may try medications which suppress the immune system. E.g., infliximab, azathioprine, methotrexate, mycophenolate mofetil and cyclosporine¹
• Radiotherapy: Radiotherapy is used when there is poor response to other treatments⁸
• Pain relief: Over-the-counter or prescription pain medications may be used to treat pain
• Physiotherapy: To help with recovery of eye muscle movement

Outcomes of Tolosa-Hunt syndrome

THS is not life-threatening, and most people recover well with treatment. However, the condition can sometimes return.⁹ In a recent study, recurrence was found to range from 9% to 71%.⁹ THS affects mainly middle-aged adults, who are thought to be at a greater risk of recurrence than children, though some studies contend this.^7,9,10 

Outcomes depend on the severity of the initial symptoms, with more severe eye paralysis and headaches being associated with poorer outcomes.⁹ Without treatment, THS can persist for weeks to months, leading to prolonged discomfort and functional impairment.

Short-term outcomes

With appropriate corticosteroid treatment, most individuals with THS experience a rapid resolution of pain within 24 to 72 hours.¹⁰ Approximately 40% of people will have no pain in the first 72 hours and 78% within a week.¹¹ However, full recovery of cranial nerve function may take weeks to months. Early administration of high-dose corticosteroids is associated with more favourable recoveries and outcomes.¹

• Pain relief: Most people feel better within a few days of starting steroid treatment
• Eye movement improvement: It can take weeks to months for people to fully recover
• Mild unresolved symptoms: Some people could have minor eye movement problems or pain even after recovery

Prognosis

Long-term outcomes of THS vary depending on individual patient factors, recurrence rates, and response to treatment.

• Cranial nerve paresis (muscular weakness) takes longer to resolve (2-8 weeks) than the associated pain¹¹
• Rarely, eye muscle weakness or paralysis persists indefinitely
  • Relapse occurs in about 50% of THS cases, with relapse intervals ranging from months to years¹¹
• Spontaneous remission can occur if left untreated (typically within 2 to 3 months)¹³
• Recurrence or relapse is rare; however, it is possible for THS to return months or years later in some people, though long-term follow-up care is poorly documented in scientific literature¹⁰
• In long-term or recurring cases, patients may experience lasting vision problems, including double vision (diplopia), drooping eyelids (ptosis) or ongoing nerve damage that affects eye movement and function
  • Psychological and functional impairments due to recurrent attacks can impact quality of life
• Long-term medication: Some people could require additional medical treatment if symptoms return

Factors affecting prognosis

Several factors influence the prognosis of THS, including:

• Better outcomes with early diagnosis and treatment
• Recurrence: Multiple recurrences tend to have a less favourable prognosis with potential long-term neurological impairment
  • Repeated episodes may necessitate long-term immunosuppressive therapy¹
• Imaging and pathophysiology: MRI evidence of granulomatous inflammation correlates with disease severity¹⁰
• Lack of response to corticosteroids warrants consideration of alternative diagnoses, such as malignancy, vasculitis, or infectious causes
• Misdiagnosis can delay appropriate treatment, leading to poor outcomes. Therefore, comprehensive diagnostic tests, including neuroimaging, laboratory tests, and biopsy in severe, recurrent cases, could be essential

Quality of life 

While THS is generally not life-threatening, it can significantly impact one's quality of life if left untreated. Chronic or recurrent episodes lead to:

• Persistent pain and discomfort
• Visual disturbances (diplopia, ptosis)
• Emotional distress and anxiety
• Occupational and daily life limitations

Follow-up care

Though THS is treatable, long-term check-ups are important. Individuals with THS should:

• See a doctor if symptoms return: New or worsening eye pain should always be evaluated
• Get regular eye exams: An ophthalmologist can check for any long-term effects on vision
• Ask about alternative treatments: If steroids cause side effects, there may be other options

FAQs

How rare is Tolosa-Hunt syndrome?

Tolosa-Hunt syndrome affects 1 to 2 per million individuals presenting with:

• One-sided eye pain
• Cranial nerve paralysis 
• Granulomas on MRI or biopsy¹²

What are the risk factors for Tolosa-Hunt syndrome?

Tolosa-Hunt syndrome is thought to be idiopathic (no known cause) and is thought to be triggered by inflammation in the region of the cavernous sinus and/or superior orbital fissure. Infection, head trauma, tumours or vascular lesions are potential triggers.¹

Is Tolosa-Hunt syndrome curable? 

There is no known cure for Tolosa-Hunt syndrome, but corticosteroids are the first-line therapy when managing the condition.

Is Tolosa-Hunt syndrome hereditary?

The exact cause of Tolosa-Hunt syndrome is unknown and is not thought to be genetically linked. Evidence points towards an idiopathic inflammatory process, with some theories suggesting a possible autoimmune element, rather than a direct genetic mutation causing the condition.² 

How long does Tolosa-Hunt syndrome last?

If left untreated, symptoms may resolve spontaneously in 2 to 3 months. However, some of the cranial nerve abnormalities may persist.¹³ In most cases Tolosa-Hunt syndrome responds quickly to corticosteroid treatment (24 to 72 hours).¹⁰ 

Summary

Tolosa-Hunt syndrome (THS) is a rare but manageable condition. THS has a generally favourable prognosis with early and appropriate treatment, however, recurrence remains a concern. While THS can cause intense pain and difficulty moving the eye, treatment with steroids usually brings relief within days. THS symptoms can sometimes return, therefore, regular follow-ups with a doctor are important. By staying informed and seeking prompt treatment, people with THS can maintain a good quality of life and prevent complications.